Form 13-F position report

LIFESTANCE HEALTH GROUP INC

Reported by SUMMIT PARTNERS L P

LFST CUSIP 53228F101 Manager CIK 0000830588

Reported 16,623,824 shares, down 6,686,291 (28.7%) from the prior quarter.

Reported value -19.9%; share count -28.7% vs. the prior quarter.

Reduced
% of reported 13F value 40.74% This manager · Q3 2026
Shares 16,623,824 Quarter-end amount reported
Reported value $199,984,603 Fair value at quarter end
Consecutive quarters held 22 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 435394000
2022-03-31 462378000
2022-06-30 254285000
2022-09-30 302764000
2022-12-31 225929438
2023-03-31 339808843
2023-06-30 417557838
2023-09-30 314197410
2023-12-31 358102724
2024-03-31 282183118
2024-06-30 205887878
2024-09-30 293526506
2024-12-31 309041478
2025-03-31 279269504
2025-06-30 216790291
2025-09-30 184385933
2025-12-31 236013994
2026-03-31 186066273
2026-06-30 249651332
2026-09-30 199984603

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for LIFESTANCE HEALTH GROUP INC held by SUMMIT PARTNERS L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 16,623,824 -6,686,291 (-28.7%) 40.74% $199,984,603 2026-10-29
Q2 2026 Reduced 23,310,115 -5,899,661 (-20.2%) 41.0% $249,651,332 2026-07-30
Q1 2026 Reduced 29,209,776 -4,314,939 (-12.9%) 27.76% $186,066,273 2026-05-08
Q4 2025 Unchanged 33,524,715 0 (0.0%) 22.46% $236,013,994 2026-02-06
Q3 2025 Reduced 33,524,715 -8,407,643 (-20.1%) 19.95% $184,385,933 2025-11-04
Q2 2025 Unchanged 41,932,358 0 (0.0%) 15.29% $216,790,291 2025-07-16
Q1 2025 Unchanged 41,932,358 0 (0.0%) 17.32% $279,269,504 2025-05-05
Q4 2024 Unchanged 41,932,358 0 (0.0%) 13.84% $309,041,478 2025-02-04
Q3 2024 Unchanged 41,932,358 0 (0.0%) 13.11% $293,526,506 2024-10-31
Q2 2024 Reduced 41,932,358 -3,802,345 (-8.3%) 12.25% $205,887,878 2024-07-18
Q1 2024 Unchanged 45,734,703 0 (0.0%) 15.56% $282,183,118 2024-05-15
Q4 2023 Unchanged 45,734,703 0 (0.0%) 13.06% $358,102,724 2024-01-12
Q3 2023 Unchanged 45,734,703 0 (0.0%) 10.77% $314,197,410 2023-10-24
Q2 2023 Unchanged 45,734,703 0 (0.0%) 30.25% $417,557,838 2023-07-21
Q1 2023 Reduced 45,734,703 -1 (0.0%) 24.56% $339,808,843 2023-04-20
Q4 2022 Added 45,734,704 +1 (0.0%) 18.44% $225,929,438 2023-02-13
Q3 2022 Unchanged 45,734,703 0 (0.0%) 21.06% $302,764,000 2022-11-04
Q2 2022 Unchanged 45,734,703 0 (0.0%) 17.0% $254,285,000 2022-07-26
Q1 2022 Unchanged 45,734,703 0 (0.0%) 20.51% $462,378,000 2022-05-11
Q4 2021 Unchanged 45,734,703 0 (0.0%) 13.93% $435,394,000 2022-02-09
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

367 managers reported LIFESTANCE HEALTH GROUP INC for Q3 2026.

Managers reporting LIFESTANCE HEALTH GROUP INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
TPG GP A LLC Reduced 79,691,702 -32,052,912 23.34% $958,691,175 20 qtrs
FMR LLC Added 59,459,199 +1,206,733 0.03% $715,294,164 22 qtrs
BlackRock Inc Added 40,758,772 +4,410,265 < 0.01% $490,328,015 9 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 17,465,725 +3,504,833 < 0.01% $210,112,672 3 qtrs
SUMMIT PARTNERS L P This report Reduced 16,623,824 -6,686,291 40.74% $199,984,603 22 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 11,379,184 +1,644,108 < 0.01% $136,891,584 3 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 10,046,351 +7,277,024 0.01% $120,859,000 17 qtrs
MARSHALL WACE LLP Added 9,955,435 +8,328,169 0.1% $119,763,882 8 qtrs
STATE STREET CORPORATION Added 9,886,791 +1,658,440 < 0.01% $118,938,096 21 qtrs
JENNISON ASSOCIATES LLC Reduced 8,710,289 -3,367,268 0.06% $104,784,775 15 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
October 29, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
16,623,824
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.